Back to Search Start Over

Purification, and characterization of a new pro-coagulant protein from Iranian Echis carinatus venom

Authors :
Sayeneh Khodadadi
Hadi Rabiei
Soroush Sardari
Hosein Mahboudi
Mohammad Ali Bayatzadeh
Nader Vazifeh Shiran
Maryam Sardabi
Mohammad Reza Akbari Eidgahi
Hamid Madanchi
Nasser Mohammadpour
Source :
Biochemistry and Biophysics Reports, Vol 38, Iss , Pp 101701- (2024)
Publication Year :
2024
Publisher :
Elsevier, 2024.

Abstract

This work aimed to purify the proteins that cause blood coagulation in the venom of the Iranian Echis carinatus snake species in a comprehensive manner. Gel filtration chromatography (GFC), Ion exchange chromatography (IEC), and Size Exclusion High-Performance Liquid Chromatography (SEC-HPLC) were utilized in the purification of the coagulation factors. The prothrombin clotting time (PRCT) and SDS-PAGE electrophoresis were performed to confirm the coagulative fractions. The fraction with the shortest coagulation time was selected. The components of this designated fraction were identified through matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF) following thorough purification. Circular dichroism (CD) was employed to determine the second structure of the coagulation factor. The crude venom (CV) was analyzed and had a total protein concentration of 97%.Furthermore, the PRCT of the crude venom solution at a concentration of 1 mg/ml was determined to be 24.19 ± 1.05 s. The dosage administered was found to be a factor in the venom's capacity to induce hemolysis. According to CD analysis, the protein under investigation had a helical structure of 16.7%, a beta structure of 41%, and a turn structure of 9.8%. CHNS proved that the purified coagulant protein had a Carbon content of 77.82%, 5.66% Hydrogen, 3.19% Nitrogen, and 0.49% Sulphur. In the present investigation, a particular type of snake venom metalloproteinase (SVMP) has undergone the process of purification and characterization and has been designated as EC-124. This purified fraction shows significant efficacy as a procoagulant. Our findings have shown that this compound has a function similar to factor X and most likely it can cause blood coagulation by activating factor II (FII).

Details

Language :
English
ISSN :
24055808
Volume :
38
Issue :
101701-
Database :
Directory of Open Access Journals
Journal :
Biochemistry and Biophysics Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.145579e512254d29a743e99d7a5e3141
Document Type :
article
Full Text :
https://doi.org/10.1016/j.bbrep.2024.101701